Type 2 Diabetes Mellitus Therapeutic Market Insights Video

According to Cognitive Market Research, the global Type 2 Diabetes Mellitus Therapeutic market size was USD 19514.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 8.80% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 7805.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 5854.35 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 4488.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.8% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 975.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 390.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.
• The SGLT2 inhibitors category is the fastest growing segment of the Type 2 Diabetes Mellitus Therapeutic industry